P450s
Showing 1 - 25 of >10,000
Atopic Dermatitis Trial (Caffeine, Metoprolol, Midazolam)
Not yet recruiting
- Atopic Dermatitis
- Caffeine
- +6 more
- (no location specified)
May 26, 2023
Chronic Myeloid Leukemia, Chronic Phase Trial in Monterrey (Dasatinib Pill, Ketoconazole Pill)
Recruiting
- Chronic Myeloid Leukemia, Chronic Phase
- Dasatinib Pill
- Ketoconazole Pill
-
Monterrey, Nuevo Leon, MexicoHospital Universitario Dr. José Eleuterio González
Nov 25, 2022
Macrophage Function
Enrolling by invitation
- Polymorphism
- Lung Inflammation
-
Research Triangle Park, North CarolinaNIEHS, Research Triangle Park
Jul 6, 2022
Atopic Dermatitis Trial in Bulgaria, United States (Nemolizumab, CYP 450 Substrates)
Recruiting
- Atopic Dermatitis
- Nemolizumab
- CYP 450 Substrates
-
North Hollywood, California
- +6 more
Nov 29, 2022
HIV Trial in Baltimore (VH4524184, Midazolam, Placebo)
Recruiting
- HIV Infections
- VH4524184
- +2 more
-
Baltimore, MarylandGSK Investigational Site
Jan 11, 2023
Malaria, Malaria, Vivax, Plasmodium Vivax Malaria Trial in Mae Sot (Dihydroartemisinin-piperaquine plus tafenoquine (450 mg
Not yet recruiting
- Malaria
- +2 more
- Dihydroartemisinin-piperaquine plus tafenoquine (450 mg adult dose)
- Chloroquine plus Tafenoquine (450 mg adult dose)
-
Mae Sot, Tak, ThailandShoklo Malaria Research Unit (SMRU)
Mar 15, 2023
Parkinson Disease Trial in Madison (Tavapadon, Carbamazepine)
Active, not recruiting
- Parkinson Disease
-
Madison, WisconsinMadison, Wisconsin
Jan 13, 2023
Antipsychotic Induced Weight Gain, Non-alcoholic Steatohepatitis (NASH) Trial in Miami (Miricorilant, Fluvoxamine)
Recruiting
- Antipsychotic Induced Weight Gain
- Non-alcoholic Steatohepatitis (NASH)
-
Miami, FloridaSite 01
Feb 3, 2023
Ulcerative Colitis (UC), Crohn's Disease Trial in Germany, Israel, United States (Risankizumab, Cytochrome P450 (CYP)
Completed
- Ulcerative Colitis (UC)
- Crohn's Disease
- Risankizumab
- Cytochrome P450 (CYP) Substrates
-
Coronado, California
- +5 more
Oct 20, 2022
Drug-Interactions Trial in Baltimore (Inje cocktail, THC Cannabis extract, THC/CBD Cannabis Extract)
Active, not recruiting
- Drug-Interactions
- Inje cocktail
- +2 more
-
Baltimore, MarylandJohns Hopkins University
Mar 21, 2022
Secondary Obliteration of Old Radical Cavities Using S53P4
Recruiting
- Mastoid Cavity
- S53P4 bioactive glass granules
-
Utrecht, NetherlandsDiakonessenhuis
Nov 1, 2023
Myopia Trial in China, India (Single vision spectacle lens, Single vision spectacle lens + S.T.O.P.® Kit 1, Single vision
Not yet recruiting
- Myopia
- Single vision spectacle lens
- +4 more
-
Tianjin, Heping District, China
- +4 more
Nov 15, 2023
Drug Intolerance, Cytochrome P450 CYP2D6 Enzyme Deficiency, Drug Effect Trial in Geneva (Pupillometry)
Terminated
- Drug Intolerance
- +2 more
- Pupillometry
-
Geneva, SwitzerlandGeneva University Hospitals, Geneva, Switzerland
Nov 24, 2022
Fibromyalgia Trial in Porto Alegre (s-Tdcs)
Active, not recruiting
- Fibromyalgia
- s-Tdcs
-
Porto Alegre, Rio Grande Do Sul, BrazilHospital de Clinicas de Porto Alegre
Jun 5, 2023
Healthy Trial in Geneva (Dextromethorphan 5 MG, Paroxetine 10Mg Tablet, Paroxetine 20Mg Tablet)
Completed
- Healthy
- Dextromethorphan 5 MG
- +2 more
-
Geneva, SwitzerlandHUG
Jan 3, 2022
Drug-drug Interactions Trial in DeLand (napabucasin, cytochrome P450 (CYP450) probe drugs or BCRP transporter substrate)
Completed
- Drug-drug Interactions
- napabucasin
- cytochrome P450 (CYP450) probe drugs or BCRP transporter substrate
-
DeLand, FloridaAccel Research Sites
Apr 4, 2022
Crohn Disease, Ulcerative Colitis Trial in Worldwide (Ustekinumab IV Infusion, Ustekinumab SC Injection, Midazolam 2 mg)
Suspended
- Crohn Disease
- Ulcerative Colitis
- Ustekinumab IV Infusion
- +7 more
-
Cypress, California
- +15 more
Jul 21, 2022
Biliary Tract Cancer Trial in Worldwide (Rilvegostomig, Placebo, Capecitabine)
Not yet recruiting
- Biliary Tract Cancer
- Rilvegostomig
- +4 more
-
Clayton, Australia
- +65 more
Oct 26, 2023
Fibromyalgia Trial in Porto Alegre (s-tDCS, a- tDCS)
Active, not recruiting
- Fibromyalgia
- s-tDCS
- a- tDCS
-
Porto Alegre, Rio Grande Do Sul, BrazilHospital de Clinicas de Porto Alegre
Apr 26, 2023
Smoking, Tobacco Trial in United States (P1213416, P1213422, P1213716)
Not yet recruiting
- Smoking, Tobacco
- P1213416
- +11 more
-
Phoenix, Arizona
- +11 more
Jul 21, 2023
Human Immunodeficiency Virus Type 1 (HIV-1) Infection Trial (Vesatolimod, Cobicistat, Voriconazole)
Not yet recruiting
- Human Immunodeficiency Virus Type 1 (HIV-1) Infection
- Vesatolimod
- +3 more
- (no location specified)
Jul 11, 2022